Compositions and Methods of Aloe Polysaccharides
AssigneeBespoke Bioscience, LLC
InventorIvan E. Danhof
Life of this patent
Estimating the term…
Abstract
The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile injectable formulation for the treatment of one or more cancers, leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, immune diseases, particularly immune related neoplasms, acquired immune deficiency syndrome, and hepatitis C.
Claims21
A method for preparing a fine powder of a polymannan extract comprising the steps of:
- weighing a specified quantity of a freeze-dried aloe powder, wherein the quantity is corrected for a moisture content;
- dissolving the freeze-dried aloe powder in deionized water to form a solution;
- adding a first volume of an organic solvent to the solution to form a first mixture;
- wherein the organic solvent to the deionized water ratio is at least 2.5:1;
- allowing the first mixture to settle for at least 8 hours;
- withdrawing a specified volume of a supernatant solution from the first mixture and adding a second volume of the organic solvent to the specified volume of the supernatant solution to form a second mixture;
- centrifuging the second mixture;
- observing for a presence of a precipitate in second mixture;
- adding a third volume of the organic solvent to first mixture if any precipitate is observed in second mixture;
- decanting the supernatant of the first mixture by siphoning, wherein the decantation is done only if no precipitate is observed in the second mixture;
- filtering the precipitate from the first mixture by using a filter paper and a suction funnel under vacuum;
- and
- recovering the powder of the polymannan extract from the suction funnel by scraping.
A method for the treatment of one or more cancers, wherein the one or more cancers are selected from the group consisting of leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, comprising the steps of:
- identifying an individual in need of treatment against the one or more cancers;
- and
- injecting a sterile injectable polymannan extract formulation two to three times in a week in a dosage sufficient to treat the one or more cancers, wherein the sterile injectable polymannan extract formulation comprises a specified quantity of very fine polymannan extract dissolved in deionized water;
- and one or more pharmaceutical preservatives.
Dependencies are inferred from the claim text.